AAAAAA
Results: 1-25/41
Authors:
El-Deiry, WS
Citation: Ws. El-deiry, Akt takes centre stage in cell-cycle deregulation, NAT CELL BI, 3(3), 2001, pp. E71-E73
Authors:
El-Deiry, WS
Citation: Ws. El-deiry, Insights into cancer therapeutic design based on p53 and TRAIL receptor signaling, CELL DEAT D, 8(11), 2001, pp. 1066-1075
Authors:
Fisher, MJ
Virmani, AK
Wu, L
Aplenc, R
Harper, JC
Powell, SM
Rebbeck, TR
Sidransky, D
Gazdar, AF
El-Deiry, WS
Citation: Mj. Fisher et al., Nucleotide substitution in the ectodomain of TRAIL receptor DR4 is associated with lung cancer and head and neck cancer, CLIN CANC R, 7(6), 2001, pp. 1688-1697
Authors:
Kim, K
Takimoto, R
Dicker, DT
Chen, YH
Gazitt, Y
El-Deiry, WS
Citation: K. Kim et al., Enhanced TRAIL sensitivity by p53 overexpression in human cancer but not normal cell lines, INT J ONCOL, 18(2), 2001, pp. 241-247
Authors:
Burns, TF
Bernhard, EJ
El-Deiry, WS
Citation: Tf. Burns et al., Tissue specific expression of p53 target genes suggests a key role for KILLER/DR5 in p53-dependent apoptosis in vivo, ONCOGENE, 20(34), 2001, pp. 4601-4612
Authors:
McDonald, ER
El-Deiry, WS
Citation: Er. Mcdonald et Ws. El-deiry, Checkpoint genes in cancer, ANN MED, 33(2), 2001, pp. 113-122
Authors:
Liu, Q
El-Deiry, WS
Gazitt, Y
Citation: Q. Liu et al., Additive effect of Apo2L/TRAIL and Adeno-p53 in the induction of apoptosisin myeloma cell lines, EXP HEMATOL, 29(8), 2001, pp. 962-970
Authors:
Takimoto, R
El-Deiry, WS
Citation: R. Takimoto et Ws. El-deiry, DNA replication blockade impairs p53-transactivation, P NAS US, 98(3), 2001, pp. 781-783
Authors:
Burns, TF
El-Deiry, WS
Citation: Tf. Burns et Ws. El-deiry, Identification of inhibitors of TRAIL-induced death (ITIDs) in the TRAIL-sensitive colon carcinoma cell line SW480 using a genetic approach, J BIOL CHEM, 276(41), 2001, pp. 37879-37886
Authors:
McDonald, ER
Chui, PC
Martelli, PF
Dicker, DT
El-Deiry, WS
Citation: Er. Mcdonald et al., Death domain mutagenesis of KILLER/DR5 reveals residues critical for apoptotic signaling, J BIOL CHEM, 276(18), 2001, pp. 14939-14945
Authors:
Meng, RD
El-Deiry, WS
Citation: Rd. Meng et Ws. El-deiry, p53-Independent upregulation of KILLER/DR5 TRAIL receptor expression by glucocorticoids and interferon-gamma, EXP CELL RE, 262(2), 2001, pp. 154-169
Authors:
Goke, R
Goke, A
Goke, B
El-Deiry, WS
Chen, YH
Citation: R. Goke et al., Pioglitazone inhibits growth of carcinoid cells and promotes TRAIL-inducedapoptosis by induction of p21(waf1/cip1), DIGESTION, 64(2), 2001, pp. 75-80
Authors:
Goldberg, GS
Jin, ZY
Ichikawa, H
Naito, A
Ohki, M
El-Deiry, WS
Tsuda, H
Citation: Gs. Goldberg et al., Global effects of anchorage on gene expression during mammary carcinoma cell growth reveal role of tumor necrosis factor-related apoptosis-inducing ligand in anoikis, CANCER RES, 61(4), 2001, pp. 1334-1337
Authors:
Meng, RD
McDonald, ER
Sheikh, MS
Fornace, AJ
El-Deiry, WS
Citation: Rd. Meng et al., The TRAIL decoy receptor TRUNDD (DcR2, TRAIL-R4) is induced by adenovirus-p53 overexpression and can delay TRAIL-, p53-, and KILLER/DR5-dependent colon cancer apoptosis, MOL THER, 1(2), 2000, pp. 130-144
Authors:
Somasundaram, K
El-Deiry, WS
Citation: K. Somasundaram et Ws. El-deiry, Tumor suppressor P53: Regulation and function, FRONT BIOSC, 5, 2000, pp. D424-D437
Authors:
MacLachlan, TK
El-Deiry, WS
Citation: Tk. Maclachlan et Ws. El-deiry, Pointing (zinc) fingers at BRCA1 targets, NAT MED, 6(12), 2000, pp. 1318-1319
Authors:
Kim, KH
Fisher, MJ
Xu, SQ
El-Deiry, WS
Citation: Kh. Kim et al., Molecular determinants of response to TRAIL in killing of normal and cancer cells, CLIN CANC R, 6(2), 2000, pp. 335-346
Authors:
Satyamoorthy, K
Chehab, NH
Waterman, MJF
Lien, MC
El-Deiry, WS
Herlyn, M
Halazonetis, TD
Citation: K. Satyamoorthy et al., Aberrant regulation and function of wild-type p53 in radioresistant melanoma cells, CELL GROWTH, 11(9), 2000, pp. 467-474
Authors:
McDonald, ER
El-Deiry, WS
Citation: Er. Mcdonald et Ws. El-deiry, Cell cycle control as a basis for cancer drug development (review), INT J ONCOL, 16(5), 2000, pp. 871-886
Authors:
Ozoren, N
Fisher, MJ
Kim, K
Liu, CX
Genin, A
Shifman, Y
Dicker, DT
Spinner, NB
Lisitsyn, NA
El-Deiry, WS
Citation: N. Ozoren et al., Homozygous deletion of the death receptor DR4 gene in a nasopharyngeal cancer cell line is associated with TRAIL resistance, INT J ONCOL, 16(5), 2000, pp. 917-925
Authors:
Takimoto, R
El-Deiry, WS
Citation: R. Takimoto et Ws. El-deiry, Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site, ONCOGENE, 19(14), 2000, pp. 1735-1743
Authors:
Wu, GS
Kim, K
El-Deiry, WS
Citation: Gs. Wu et al., Killer/DR5, a novel DNA-damage inducible death receptor gene, links the p53-tumor suppressor to caspase activation and apoptotic death, ADV EXP MED, 465, 2000, pp. 143-151
Authors:
MacLachlan, TK
Somasundaram, K
Sgagias, M
Shifman, Y
Muschel, RJ
Cowan, KH
El-Deiry, WS
Citation: Tk. Maclachlan et al., BRCA1 effects on the cell cycle and the DNA damage response are linked to altered gene expression, J BIOL CHEM, 275(4), 2000, pp. 2777-2785
Authors:
Ozoren, N
Kim, KH
Burns, TF
Dicker, DT
Moscioni, AD
El-Deiry, WS
Citation: N. Ozoren et al., The caspase 9 inhibitor Z-LEHD-FMK protects human liver cells while permitting death of cancer cells exposed to tumor necrosis factor-related apoptosis-inducing ligand, CANCER RES, 60(22), 2000, pp. 6259-6265
Authors:
Mitchell, KO
Ricci, MS
Miyashita, T
Dicker, DT
Jin, ZY
Reed, JC
El-Deiry, WS
Citation: Ko. Mitchell et al., Bax is a transcriptional target and mediator of c-Myc-induced apoptosis, CANCER RES, 60(22), 2000, pp. 6318-6325